文献速递创伤与烧伤重症综合管理与镇静镇痛

钝性实质性脏器损伤患者早期药物性血栓预防是否明智

Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision?
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论钝性腹部实质性脏器损伤非手术治疗患者早期(≤48小时)启动药物性血栓预防与深静脉血栓和肺栓塞发生率降低相关,且不增加输血、非手术治疗失败或死亡。

该研究为2013—2014年美国外科医师学会创伤质量改进项目的回顾性分析,纳入接受非手术治疗的成人钝性实质性脏器损伤患者36187例,按药物性血栓预防启动时间分为早期(≤48小时)、晚期(>48小时)和无预防三组。校正混杂因素后,早期药物性血栓预防组深静脉血栓(p=0.01)和肺栓塞(p=0.01)发生率低于无预防组和晚期组;三组在预防后红细胞输注、非手术治疗失败和死亡率方面无差异。作者认为,对接受非手术治疗的钝性腹部实质性脏器损伤患者,应考虑早期启动药物性血栓预防。证据等级为治疗性,V级。

要点

  • 36187例接受非手术治疗的成人钝性实质性脏器损伤患者中,36%接受了药物性血栓预防,其中早期(≤48小时)占37%(n=4819),晚期(>48小时)占63%(n=8208)。
  • 校正混杂因素后,早期药物性血栓预防组深静脉血栓(p=0.01)和肺栓塞(p=0.01)发生率低于无预防组和晚期组。
  • 三组在预防后红细胞输注、非手术治疗失败和死亡率方面无差异。
  • 作者认为,对接受非手术治疗的钝性腹部实质性脏器损伤患者,应考虑早期启动药物性血栓预防。
  • 证据等级为治疗性,V级。

适用人群与场景

  • 成人创伤患者(年龄≥18岁)
  • 钝性实质性脏器损伤
  • 接受非手术治疗

诊断标准与关键阈值

  • 按药物性血栓预防启动时间分组:早期为≤48小时,晚期为>48小时,另设无预防组

研究设计与关键结果

  • 研究类型:2013—2014年美国外科医师学会创伤质量改进项目的回顾性分析
  • 样本量:36187例符合纳入标准;平均年龄49.5±19岁;36%接受药物性血栓预防(早期37%(n=4819),晚期63%(n=8208))
  • 主要终点:校正混杂因素后,早期药物性血栓预防组深静脉血栓(p=0.01)和肺栓塞(p=0.01)发生率低于无预防组和晚期组
  • 其他终点:三组在预防后红细胞输注、非手术治疗失败和死亡率方面无差异

证据类型、等级与局限

  • 证据类型:回顾性分析;证据等级:治疗性,V级
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,对接受非手术治疗的钝性腹部实质性脏器损伤患者,应考虑早期启动药物性血栓预防;该做法与深静脉血栓和肺栓塞发生率降低相关,且预防后红细胞输注、非手术治疗失败和死亡率无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The optimal time to initiate chemical thromboprophylaxis (CTP) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOI) remains controversial. The aim of our study was to assess the impact of early initiation of CTP in patients with blunt abdominal SOIs.

METHODS: We performed a 2-year (2013-2014) retrospective analysis of American College of Surgeons Trauma Quality Improvement Program. We included all adult trauma patients (age, ≥ 18 years) with blunt SOI who underwent NOM. Patients were stratified into three groups based on timing of CTP (early, ≤48 hours of injury; late, >48 hours of injury,; and no prophylaxis group). Our primary outcomes were rates of failure of NOM, pRBC transfusion, and mortality. Our secondary outcomes were the rate of venous thromboembolic (VTE) events (i.e., deep venous thrombosis [DVT] and/or pulmonary embolism [PE]) and length of stay.

RESULTS: A total of 36,187 patients met the inclusion criteria. Mean age was 49.5 ± 19 years and 36% of patients received CTP (early, 37% (n = 4,819) versus late, 63% (n = 8,208)). After controlling for confounders, patients receiving early CTP had lower rates of DVT (p = 0.01) and PE (p = 0.01) compared with the no prophylaxis and late CTP groups. There was no difference between the three groups regarding the postprophylaxis pRBC transfusions, failure of NOM, and mortality.

CONCLUSION: Our results suggest that in patients undergoing NOM of blunt abdominal SOI, early initiation of CTP should be considered. It is associated with decreased rates of DVT and PE, with no significant difference in post prophylaxis pRBC transfusion, failure of nonoperative management, and mortality.

LEVEL OF EVIDENCE: Therapeutic, level V.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Skarupa D, Hanna K, Zeeshan M, et al. Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision? J Trauma Acute Care Surg. 2019. PMID: 31299694. doi:10.1097/TA.0000000000002438

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。